Wharton Business Group, LLC Merck & Co., Inc. Transaction History

Wharton Business Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$123.8 - $132.96 $5,571 - $5,983	-45 Reduced 2.67%	1,641 $203,000
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $190,922 - $222,467	1,686 New	1,686 $222,000
Q2 2021 Aug 11, 2021	SELL	$70.31 - $77.77 $227,523 - $251,663	-3,236 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$68.86 - $81.11 $3,098 - $3,649	45 Added 1.41%	3,236 $249,000
Q3 2020 Nov 06, 2020	BUY	$73.18 - $82.95 $233,517 - $264,693	3,191 New	3,191 $265,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $257B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Wharton Business Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Wharton Business Group, LLC with notifications on news.